Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with acute decompensated heart failure: a systematic review and meta-analysis.
Jerald PelayoKevin Bryan U LoEric PetersonCarly DeFariaAtif NehviRicardo TorresMuhammad Haisum MaqsoodMinaam FarooqRoy O MathewJanani RangaswamiPublished in: Expert review of cardiovascular therapy (2021)
Maintaining or initiating patients with HFrEF hospitalized for acute decompensated heart failure (ADHF) on ACEi/ARB is associated with a reduce risk of mortality and 1-year admissions, but the effect size is lower among those with HFpEF with more heterogeneous outcomes.
Keyphrases
- angiotensin converting enzyme
- heart failure
- angiotensin ii
- liver failure
- vascular smooth muscle cells
- left ventricular
- acute heart failure
- cardiac resynchronization therapy
- cardiovascular events
- cardiovascular disease
- risk factors
- respiratory failure
- coronary artery disease
- drug induced
- intensive care unit
- type diabetes
- extracorporeal membrane oxygenation
- insulin resistance
- glycemic control
- aortic dissection
- acute respiratory distress syndrome
- mechanical ventilation